Models Name |
Cat.No. |
Animal Type |
Disease Area |
Breast cancer (in situ ductal carcinoma), patient-derived xenograft (PHTX14B), in nude mouse (Balb/c)
|
AB35864 |
mouse |
Cancer,breast |
Breast cancer (in situ ductal carcinoma), xenograft (BT474 (c-Cbl-overexpressing/ER positive/tamoxifen-resistant)), in athymic nude mouse (Balb/c)
|
AB35865 |
mouse |
Cancer,breast (in situ ductal carcinoma) |
Breast cancer (in situ ductal carcinoma), xenograft (BT474 (disulfiram/copper-treated)), in nude mouse (Balb/c)
|
AB35866 |
mouse |
Cancer,breast (in situ ductal carcinoma) |
Breast cancer (in situ ductal carcinoma), xenograft (BT474 (ER positive/tamoxifen-resistant)), in athymic nude mouse (Balb/c)
|
AB35867 |
mouse |
Cancer,breast (in situ ductal carcinoma) |
Breast cancer (in situ ductal carcinoma), xenograft (BT474 (HER2 [ERBB2]-overexpressing), in nude mouse (Balb/c)
|
AB35868 |
mouse |
Cancer,breast (in situ ductal carcinoma) |
Breast cancer (in situ ductal carcinoma), xenograft (BT474 (HER2 [ERBB2]-positive)), in nude mouse (Balb/c)
|
AB35869 |
mouse |
Cancer,breast (in situ ductal carcinoma) |
Breast cancer (in situ ductal carcinoma), xenograft (BT474 (HER2 [ERBB2]-positive))/17beta-estradiol-induced, in athymic nude mouse (Blab/c)
|
AB35870 |
mouse |
Cancer,breast (in situ ductal carcinoma) |
Breast cancer (in situ ductal carcinoma), xenograft (BT474 (trastuzumab-resistant)), in immunosuppressed nude mouse (Balb/c)
|
AB35871 |
mouse |
Cancer,breast (in situ ductal carcinoma) |
Breast cancer (in situ ductal carcinoma), xenograft (BT474 trastuzumab-resistant)/17beta-estradiol-induced, in nude mouse
|
AB35872 |
mouse |
Cancer,breast (in situ ductal carcinoma) |
Breast cancer (in situ ductal carcinoma), xenograft (BT474), in mouse (Balb/c)
|
AB35873 |
mouse |
Cancer,breast (in situ ductal carcinoma) |